Urinary Biomarkers of Polycyclic Aromatic Hydrocarbons and Timing of Pubertal Development: The California PAH Study

From the aDepartment of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA

bDepartment of Medicine (Oncology), Stanford University School of Medicine, Stanford, CA

cStanford Cancer Institute, Stanford University School of Medicine, Stanford, CA

dDivision of Hematology and Oncology, UC Davis Comprehensive Cancer Center, University of California, Davis, CA

eDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY

fHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY

gDepartment of Population and Public Health Sciences, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA

hZero Breast Cancer, San Rafael, CA

iDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY

jLamont Doherty Earth Observatory, Columbia University, Palisades, NY.

Submitted December 20, 2021; accepted July 22, 2022

The California PAH Study was supported by grants from the California Breast Cancer Research Program (22UB-2308 to E.M.J.) and the National Cancer Institute (CA138638 to E.M.J.). This work was also supported by grants from the National Institute of Environmental Health Sciences (P30ES009089 and 1S10OD020058).

The authors report no conflicts of interest.

Upon reasonable request and with Institutional Review Board approval, researchers may request access to study data and computing code by contacting the corresponding author.

Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com).

Correspondence: Esther M. John, Stanford University School of Medicine, 3145 Porter Drive, Suite E223, MC 5393, Palo Alto, CA 94304. E-mail: [email protected].

留言 (0)

沒有登入
gif